Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.

Wong FS, Hu C, Zhang L, Du W, Alexopoulou L, Flavell RA, Wen L.

Ann N Y Acad Sci. 2008 Dec;1150:146-8. doi: 10.1196/annals.1447.039.

PMID:
19120284
2.

IDO mediates TLR9-driven protection from experimental autoimmune diabetes.

Fallarino F, Volpi C, Zelante T, Vacca C, Calvitti M, Fioretti MC, Puccetti P, Romani L, Grohmann U.

J Immunol. 2009 Nov 15;183(10):6303-12. doi: 10.4049/jimmunol.0901577. Epub 2009 Oct 19. Erratum in: J Immunol. 2010 Jun 15;184(12):7316.

3.

The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.

Lien E, Zipris D.

Curr Mol Med. 2009 Feb;9(1):52-68. Review.

PMID:
19199942
4.

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.

Krieg AM, Vollmer J.

Immunol Rev. 2007 Dec;220:251-69. Review.

PMID:
17979852
5.

Toll-like receptors in multiple sclerosis mouse experimental models.

Marta M.

Ann N Y Acad Sci. 2009 Sep;1173:458-62. doi: 10.1111/j.1749-6632.2009.04849.x.

PMID:
19758186
6.
7.

TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain.

Sørensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR.

J Immunol. 2008 Dec 15;181(12):8604-12.

8.

Genetic analysis of the innate immune responses in wild-derived inbred strains of mice.

Stephan K, Smirnova I, Jacque B, Poltorak A.

Eur J Immunol. 2007 Jan;37(1):212-23.

9.

TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.

Abou Fakher FH, Rachinel N, Klimczak M, Louis J, Doyen N.

J Immunol. 2009 Feb 1;182(3):1386-96.

10.

TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.

Holm CK, Petersen CC, Hvid M, Petersen L, Paludan SR, Deleuran B, Hokland M.

J Immunol. 2009 Oct 1;183(7):4422-31. doi: 10.4049/jimmunol.0804318. Epub 2009 Sep 11.

11.

Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.

Jiang F, Yoshida T, Nakaki F, Terawaki S, Chikuma S, Kato Y, Okazaki IM, Honjo T, Okazaki T.

Int Immunol. 2009 May;21(5):499-509. doi: 10.1093/intimm/dxp020. Epub 2009 Mar 4.

PMID:
19261693
12.

Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.

Mayo S, Kohler W, Kumar V, Quinn A.

Clin Immunol. 2006 Feb-Mar;118(2-3):219-28. Epub 2005 Nov 21.

PMID:
16301001
13.

TLR3 deletion limits mortality and disease severity due to Phlebovirus infection.

Gowen BB, Hoopes JD, Wong MH, Jung KH, Isakson KC, Alexopoulou L, Flavell RA, Sidwell RW.

J Immunol. 2006 Nov 1;177(9):6301-7.

14.

Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.

Sjölinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR.

Infect Immun. 2008 Nov;76(11):5421-8. doi: 10.1128/IAI.00615-08. Epub 2008 Sep 15.

15.

Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes.

Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, Esterhuizen TM.

Tissue Antigens. 2005 Aug;66(2):125-30.

PMID:
16029432
16.

Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury.

Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, Alexopoulou L, Li N, Flavell RA, Bowles NE, Vallejo JG.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H251-8. Epub 2006 Aug 25.

PMID:
16936008
17.

The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.

Tai N, Wong FS, Wen L.

J Autoimmun. 2016 Jul;71:26-34. doi: 10.1016/j.jaut.2016.03.006. Epub 2016 Mar 24. Review.

18.

TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response.

Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL.

Eur J Immunol. 2007 Oct;37(10):2847-55.

19.

Role of innate immunity in triggering and tuning of autoimmune diabetes.

Kim HS, Lee MS.

Curr Mol Med. 2009 Feb;9(1):30-44. Review.

PMID:
19199940
20.

TLR9 in health and disease.

Vollmer J.

Int Rev Immunol. 2006 May-Aug;25(3-4):155-81. Review.

PMID:
16818370

Supplemental Content

Support Center